DE69330638T2 - Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem - Google Patents
Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödemInfo
- Publication number
- DE69330638T2 DE69330638T2 DE69330638T DE69330638T DE69330638T2 DE 69330638 T2 DE69330638 T2 DE 69330638T2 DE 69330638 T DE69330638 T DE 69330638T DE 69330638 T DE69330638 T DE 69330638T DE 69330638 T2 DE69330638 T2 DE 69330638T2
- Authority
- DE
- Germany
- Prior art keywords
- dichlorophenyl
- diamino
- triazine
- edm
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929203483A GB9203483D0 (en) | 1992-02-19 | 1992-02-19 | Anti-inflammatory compounds |
PCT/GB1993/000341 WO1993016700A1 (en) | 1992-02-19 | 1993-02-18 | Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and ×dema |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69330638D1 DE69330638D1 (de) | 2001-09-27 |
DE69330638T2 true DE69330638T2 (de) | 2002-06-27 |
Family
ID=10710643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69330638T Expired - Fee Related DE69330638T2 (de) | 1992-02-19 | 1993-02-18 | Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem |
Country Status (18)
Country | Link |
---|---|
US (1) | US5712277A (zh) |
EP (1) | EP0626851B1 (zh) |
KR (1) | KR950700067A (zh) |
AT (1) | ATE204476T1 (zh) |
AU (1) | AU684711B2 (zh) |
CA (1) | CA2129043C (zh) |
CY (1) | CY2299B1 (zh) |
DE (1) | DE69330638T2 (zh) |
DK (1) | DK0626851T3 (zh) |
ES (1) | ES2162813T3 (zh) |
GB (2) | GB9203483D0 (zh) |
GR (1) | GR3036958T3 (zh) |
IL (1) | IL104775A (zh) |
MX (1) | MX9300927A (zh) |
NZ (1) | NZ249197A (zh) |
PT (1) | PT626851E (zh) |
TW (1) | TW226331B (zh) |
WO (1) | WO1993016700A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9424766D0 (en) * | 1994-12-07 | 1995-02-08 | Wellcome Found | Pharmaceutical composition |
RU2145602C1 (ru) * | 1994-12-30 | 2000-02-20 | Де Вэллкам Фаундейшн Лимитед | Способы получения ламотриджина, промежуточные соединения и способ получения фармацевтической композиции |
GB9625795D0 (en) * | 1996-12-12 | 1997-01-29 | Smithkline Beecham Plc | Novel treatment |
GB9726987D0 (en) | 1997-12-22 | 1998-02-18 | Glaxo Group Ltd | Compounds |
ATE303162T1 (de) * | 1999-04-09 | 2005-09-15 | Euro Celtique Sa | Natrium kanalblocker zusammensetzungen und deren verwendung |
ES2253579T3 (es) | 2001-09-03 | 2006-06-01 | Newron Pharmaceuticals S.P.A. | Composicion farmaceutica que comprende gabapentina o un analogo suyo y una alfa-aminoamida y su uso analgesico. |
JP5319920B2 (ja) * | 2004-09-10 | 2013-10-16 | ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー | ナトリウムおよび/またはカルシウムチャンネル選択的調節因子として活性のある医薬の製造のための(ハロベンジルオキシ)ベンジルアミノ−プロパンアミドの使用 |
US10576086B2 (en) * | 2015-06-12 | 2020-03-03 | University Of Greenwich | Triazine derivatives as interferon-gamma inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3637688A (en) * | 1970-01-09 | 1972-01-25 | American Home Prod | 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines |
US4310551A (en) * | 1979-03-19 | 1982-01-12 | Diamond Shamrock Corporation | Pharmacologically active substituted 1,2,4-triazines |
AU530999B2 (en) * | 1979-06-01 | 1983-08-04 | Wellcome Foundation Limited, The | Substituted amino triazines and their use in treatment of cns disorders |
GB8613183D0 (en) * | 1986-05-30 | 1986-07-02 | Wellcome Found | Triazine salt |
GB9012312D0 (en) * | 1990-06-01 | 1990-07-18 | Wellcome Found | Pharmacologically active cns compounds |
-
1992
- 1992-02-19 GB GB929203483A patent/GB9203483D0/en active Pending
-
1993
- 1993-02-18 DK DK93904225T patent/DK0626851T3/da active
- 1993-02-18 KR KR1019940702885A patent/KR950700067A/ko not_active IP Right Cessation
- 1993-02-18 WO PCT/GB1993/000341 patent/WO1993016700A1/en active IP Right Grant
- 1993-02-18 DE DE69330638T patent/DE69330638T2/de not_active Expired - Fee Related
- 1993-02-18 GB GB9414348A patent/GB2277265B/en not_active Revoked
- 1993-02-18 CA CA002129043A patent/CA2129043C/en not_active Expired - Fee Related
- 1993-02-18 AT AT93904225T patent/ATE204476T1/de not_active IP Right Cessation
- 1993-02-18 NZ NZ249197A patent/NZ249197A/en unknown
- 1993-02-18 EP EP93904225A patent/EP0626851B1/en not_active Expired - Lifetime
- 1993-02-18 PT PT93904225T patent/PT626851E/pt unknown
- 1993-02-18 ES ES93904225T patent/ES2162813T3/es not_active Expired - Lifetime
- 1993-02-18 IL IL10477593A patent/IL104775A/xx not_active IP Right Cessation
- 1993-02-18 TW TW082101145A patent/TW226331B/zh active
- 1993-02-18 AU AU35092/93A patent/AU684711B2/en not_active Ceased
- 1993-02-19 MX MX9300927A patent/MX9300927A/es not_active IP Right Cessation
-
1996
- 1996-07-15 US US08/680,111 patent/US5712277A/en not_active Expired - Fee Related
-
2001
- 2001-10-22 GR GR20010401827T patent/GR3036958T3/el not_active IP Right Cessation
-
2002
- 2002-10-14 CY CY0200058A patent/CY2299B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GB9414348D0 (en) | 1994-09-07 |
TW226331B (zh) | 1994-07-11 |
IL104775A0 (en) | 1993-06-10 |
PT626851E (pt) | 2002-02-28 |
WO1993016700A1 (en) | 1993-09-02 |
GB2277265A (en) | 1994-10-26 |
CA2129043C (en) | 2004-01-27 |
US5712277A (en) | 1998-01-27 |
IL104775A (en) | 1997-02-18 |
NZ249197A (en) | 1997-05-26 |
ATE204476T1 (de) | 2001-09-15 |
CA2129043A1 (en) | 1993-09-02 |
CY2299B1 (en) | 2003-07-04 |
GB2277265B (en) | 1996-01-10 |
MX9300927A (es) | 1994-08-31 |
KR950700067A (ko) | 1995-01-16 |
EP0626851B1 (en) | 2001-08-22 |
GB9203483D0 (en) | 1992-04-08 |
ES2162813T3 (es) | 2002-01-16 |
AU3509293A (en) | 1993-09-13 |
DK0626851T3 (da) | 2001-12-03 |
JPH07503968A (ja) | 1995-04-27 |
DE69330638D1 (de) | 2001-09-27 |
GR3036958T3 (en) | 2002-01-31 |
EP0626851A1 (en) | 1994-12-07 |
JP3713271B2 (ja) | 2005-11-09 |
AU684711B2 (en) | 1998-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
DE69012261T2 (de) | Verwendung von Sertralin zur Behandlung verfrühter Ejakulation. | |
ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
DE68923151D1 (de) | Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen. | |
DE69521536T2 (de) | Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten | |
DE69330638T2 (de) | Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem | |
DE69304843D1 (de) | Methode zur Behandlung von Haarausfall | |
ES2157961T3 (es) | Inhibicion del hirsutismo y la alopecia en mujeres. | |
DE69307702D1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
DE69424415D1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
ATE254919T1 (de) | Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8 | |
ATE136463T1 (de) | Verwendung von 1,2,3,4-tetrahydroacridinen zur behandlung von aids, sowie verbindungen | |
DE69429538T2 (de) | Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen | |
DE69218544D1 (de) | Verwendung von BMY 14802 zur Behandlung von Angstzuständen bei Patienten mit Benzodiazepin-Entzugserscheinungen | |
ATE147980T1 (de) | Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4,-triaz nisethionat zur behandlung und vorbeugung von drogenabhaengigkeit,-toleranz und- sensibilisierung | |
MX9701528A (es) | Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer. | |
MX9706404A (es) | Metodo para tratar deplecion de adenosina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |